Cancer of the Genitourinary Tract Learning Library
Cancers of the genitourinary tract affect tens of thousands of Americans every year. Cancers of the genitourinary tract involve the urinary and genital organs including the bladder, ureters, urethra, testes, prostate, and penis.
Clinical Practice Resources
Shared Decision Making in Prostate Cancer
This resource was developed by ONS through an educational grant from Astellas and Pfizer Inc.
Prostate Cancer and Sexual Health Resource
This resource was developed by ONS through an educational grant from Astellas and Pfizer Inc.
Case Studies
mCSPC Education: Shared Decision-Making When Starting mCSPC Treatment
This resource was developed by ONS through an educational grant from Astellas and Pfizer Inc. ONS is solely responsible for the criteria, objectives, content, quality, and scientific integrity of its programs and publications.
Download the facilitator guide if you'd like to use the case study in a group setting such as a staff meeting or chapter meeting.
mCSPC Education: Symptom Management During Treatment of mCSPC
This resource was developed by ONS through an educational grant from Astellas and Pfizer Inc. ONS is solely responsible for the criteria, objectives, content, quality, and scientific integrity of its programs and publications.
Download the facilitator guide if you'd like to use the case study in a group setting such as a staff meeting or chapter meeting.
Advanced and Metastatic Urothelial Cancer: Advanced Treatment Options Case Study
Produced by ONS with an educational grant from Seagen Inc.
Download the facilitator guide if you'd like to use the case study in a group setting such as a staff meeting or chapter meeting.
Advanced and Metastatic Urothelial Cancer: Care Coordination Case Study
Produced by ONS with an educational grant from Seagen Inc.
Download the facilitator guide if you'd like to use the case study in a group setting such as a staff meeting or chapter meeting.
Podcasts
Episode 113: Manage Cancer-Related Hot Flashes with ONS Guidelines
Episode 114: Intravesicular Chemotherapy Considerations for Oncology Nurses
Episode 133: Treatment Advancements for Advanced or Metastatic Urothelial Cancer
Produced by ONS with an educational grant from Seagen Inc.
Episode 141: Care Coordination for Urothelial Cancer
Produced by ONS with an educational grant from Seagen Inc.
Episode 149: Health Disparities and Barriers in Metastatic Castration-Sensitive Prostate Cancer
Astellas and Pfizer Inc. provided support for this podcast episode through an educational grant.
Episode 154: New Drug Approvals for Metastatic Castration-Sensitive Prostate Cancer
Astellas and Pfizer Inc. provided support for this podcast episode through an educational grant.
Articles
ONS Voice articles:
Oncology Drug Reference Sheet: Darolutamide (for mHSPC)
Hispanic Patients Are at Higher Risk for Aggressive Prostate Cancer but Less Likely to Get Treatment
FDA Approves First Adenoviral Vector-Based Gene Therapy for High-Risk, BCG Unresponsive, Non-Muscle- Invasive Bladder Cancer
Chemo Combo May Be a Bladder Cancer Treatment Alternative During BCG Shortage
Genetic Disorder Reference Sheet: HOXB13 (prostate cancer biomarker)
Healthy Lifestyles Reduce Prostate Cancer Mortality in Patients with Genetic Risk
Caregiving for Metastatic Prostate Cancer Is Nearly a Full-Time Job
Testicular Cancer Survivors May Need Fewer Monitoring Scans
E-Cigarettes Increase Risk of Lung and Bladder Cancer More Than Traditional Cigarettes
New Radiopharmaceutical Improves Survival in Advanced Prostate Cancer
Nursing Considerations for Bladder Cancer Survivorship Care
Nurses Are Key to Patients Navigating Genitourinary Cancers
Testicular Cancer Treatment and Survival Rates Are Improving
Prostate Cancer Prevention, Screening, Treatment, and Survivorship Recommendations
Clinical Journal of Oncology Nursing articles:
Avelumab First-Line Maintenance Therapy: Managing Patients with Advanced Urothelial Carcinoma
Genitourinary Distress: Common Side Effect
Hot Flashes: Clinical Summary of the ONS Guidelines for Cancer Treatment- Related Hot Flashes in Women With Breast Cancer and Men With Prostate Cancer
Minimizing Staff Exposure to Antineoplastic Agents During Intravesical Therapy
Oncology Nursing Forum articles:
Understanding Men's Experiences with Prostate Cancer Stigma: A Qualitative Study
The Ecology of Patients' Sexual Health Adjustment After Prostate Cancer Treatment: The Influence of the Social and Healthcare Environment
Gender Differences in Bladder Cancer Treatment Decision Making
Improving Self-Efficacy and Self-Care in Adult Patients With a Urinary Diversion: A Pilot Study
Webinars
Discussing Treatment Options for Patients with Metastatic Castration-Sensitive Prostate Cancer
This resource was developed by ONS through an educational grant from Astellas and Pfizer Inc.
Download the facilitator guide if you'd like to use the case study in a group setting such as a staff meeting or chapter meeting.
Treatment Options for Metastatic Castration-Sensitive Prostate Cancer (mCSPC): Managing Side Effects
This resource was developed by ONS through an educational grant from Astellas and Pfizer Inc.
Download the facilitator guide if you'd like to use the case study in a group setting such as a staff meeting or chapter meeting.
Advanced and Metastatic Urothelial Cancer: Advanced Treatment Options Webinar
Produced by ONS with an educational grant from Seagen Inc.
Download the facilitator guide if you'd like to use the case study in a group setting such as a staff meeting or chapter meeting.
Advanced and Metastatic Urothelial Cancer: Care Coordination Webinar
Produced by ONS with an educational grant from Seagen Inc.
Download the facilitator guide if you'd like to use the case study in a group setting such as a staff meeting or chapter meeting.
Patient and Family Resources
Evidence-based Treatment of Advanced or Metastatic Urothelial Cancer: A Patient and Family Resource
Produced by ONS with an educational grant from Seagen Inc.
Advanced and Metastatic Urothelial Cancer: Clinical Practice Resource
Produced by ONS with an educational grant from Seagen Inc.